# Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention

Study · id `cardio:ct-nct03049657` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03049657](<https://clinicaltrials.gov/study/NCT03049657>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03049657

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 220 participants.

## Technical summary

Registry record NCT03049657. Randomized; no masking; primary purpose other. Start 2016-02-02 (actual); primary completion 2017-03-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 220 participants (enrolled count; ClinicalTrials.gov record NCT03049657, source copy `cardio:ctgov-nct03049657-2019-04-12`, retrieved 2026-10-26)
- Started: 2016-02-02 (actual) (ClinicalTrials.gov record NCT03049657, source copy `cardio:ctgov-nct03049657-2019-04-12`, retrieved 2026-10-26)
- Primary completion: 2017-03-31 (actual) (ClinicalTrials.gov record NCT03049657, source copy `cardio:ctgov-nct03049657-2019-04-12`, retrieved 2026-10-26)
- Completion: 2019-01-28 (actual) (ClinicalTrials.gov record NCT03049657, source copy `cardio:ctgov-nct03049657-2019-04-12`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT03049657, source copy `cardio:ctgov-nct03049657-2019-04-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03049657-2019-04-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention
- Condition: Coronary Artery Disease
- Condition: Drug-eluting Stent
- Intervention (Device): Angiolite
- Intervention (Device): Xience
- Lead sponsor: Cardiva2 S.L.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 4b06938897f1b4f0d05d2ce671109a1f3a4520215f854266738a3446e298885b
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
